Single nucleotide polymorphism in gene encoding transcription factor prep1 is associated with HIV-1-associated dementia

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Bol, Sebastiaan M ^a   Booiman, Thijs ^a   van Manen, Daniëlle ^a   Bunnik, Evelien M ^a   van Sighem, Ard I ^b   Sieberer, Margit ^a   Boeser Nunnink, Brigitte ^a   de Wolf, Frank ^b,c   Schuitemaker, Hanneke ^a   Portegies, Peter ^d,e   Kootstra, Neeltje A ^a   van't Wout, Angélique B ^a  

^a SANQUIN RESEARCH   (Netherlands)

^b STICHTING HIV MONITORING   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PREP1; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CCR5; HOMEODOMAIN PROTEIN; PKNOX1 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ALLELE; APOE GENE; ARTICLE; BRAIN INFECTION; CASE CONTROL STUDY; CCL2 GENE; CCL3 GENE; CCL5 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL GENE; DYRK1A GENE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MCP 1 GENE; MOAP1 GENE; MONOCYTE; OBSERVATIONAL STUDY; PATHOGENESIS; PDE8A GENE; PREP1 GENE; PREVALENCE; PROMOTER REGION; PROTEIN BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; SPOCK3 GENE; TNFA GENE; VIRUS LOAD; VIRUS REPLICATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS DEMENTIA COMPLEX; CASE-CONTROL STUDIES; CHEMOKINE CCL2; HIV INFECTIONS; HOMEODOMAIN PROTEINS; HUMANS; MACROPHAGES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5;

EID: 84856742806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030990     Document Type: Article

References (64)

1. Vago L, Castagna A, Lazzarin A, Trabattoni G, Cinque P, et al. (1993) Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine. J Acquir Immune Defic Syndr 6: 42-45.
2. Portegies P, Enting RH, De Gans J, Algra PR, Derix MM, et al. (1993) Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS 7: 669-675.
3. d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, et al. (2004) Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 55: 320-328.
4. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, et al. (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63: 213-221.
5. Simioni S, Cavassini M, Annoni JM, Rimbault AA, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250.
6. Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, et al. (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 75: 1150-1158.
7. Heaton RK, Clifford DB, Franklin DR (Jr.), Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
8. Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, et al. (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS.
9. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P, (2010) HIV-1 infection and cognitive impairment in the cART-era: a review. AIDS.
10. Bol SM, Cobos-Jiménez V, Kootstra NA, Van't Wout AB, (2011) HIV-1 and the macrophage. Future Virology 6: 187-208.
11. Peluso R, Haase A, Stowring L, Edwards M, Ventura P, (1985) A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 147: 231-236.
12. Gonzalez-Scarano F, Martin-Garcia J, (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81.
13. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB, (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83: 7089-7093.
14. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, et al. (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705-711.
15. Pulliam L, West D, Haigwood N, Swanson RA, (1993) HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res Hum Retroviruses 9: 439-444.
16. Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A, (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37: 373-380.
17. Kaul M, Lipton SA, (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 96: 8212-8216.
18. Patel CA, Mukhtar M, Pomerantz RJ, (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 74: 9717-9726.
19. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, et al. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176: 1703-1718.
20. Achim CL, Heyes MP, Wiley CA, (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 91: 2769-2775.
21. Griffin DE, Wesselingh SL, McArthur JC, (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 35: 592-597.
22. Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, et al. (1994) Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68: 4628-4635.
23. Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, et al. (1995) Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 181: 735-745.
24. Jiang ZG, Piggee C, Heyes MP, Murphy C, Quearry B, et al. (2001) Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol 117: 97-107.
25. Glass JD, Fedor H, Wesselingh SL, McArthur JC, (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762.
26. Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, et al. (1996) Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A 93: 700-704.
27. Seilhean D, Kobayashi K, He Y, Uchihara T, Rosenblum O, et al. (1997) Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol 93: 508-517.
28. Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P, (2008) Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol 63: 366-376.
29. Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, et al. (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49: 780-786.
30. Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, et al. (2010) HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS 24: 1163-1170.
31. Van Rij RP, Portegies P, Hallaby T, Lange JMA, De Roda Husman AM, et al. (1999) Reduced prevalence of the CCR5 D32 heterozygous genotype in HIV-1 infected individuals with AIDS dementia complex. J Infect Dis 180: 854-857.
32. Levine AJ, Singer EJ, Sinsheimer JS, Hinkin CH, Papp J, et al. (2009) CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehav HIV Med 1: 1-7.
33. Rovin BH, Lu L, Saxena R, (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259: 344-348.
34. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, et al. (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 99: 13795-13800.
35. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.
36. Kroeger KM, Carville KS, Abraham LJ, (1997) The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34: 391-399.
37. Shiramizu B, Lau E, Tamamoto A, Uniatowski J, Troelstrup D, (2006) Feasibility assessment of cerebrospinal fluid from HIV-1-infected children for HIV proviral DNA and monocyte chemoattractant protein 1 alleles. J Investig Med 54: 468-472.
38. Quasney MW, Zhang Q, Sargent S, Mynatt M, Glass J, et al. (2001) Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia. Ann Neurol 50: 157-162.
39. Wright EK (Jr.), Page SH, Barber SA, Clements JE, (2008) Prep1/Pbx2 complexes regulate CCL2 expression through the -2578 guanine polymorphism. Genes Immun 9: 419-430.
40. Singh KK, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, et al. (2004) CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. J Neuroimmunol 157: 185-192.
41. Bol SM, Moerland PD, Limou S, Van Remmerden Y, Coulonges C, et al. (2011) Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PLoS ONE 6: e17190.
42. Navia BA, Jordan BD, Price RW, (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517-524.
43. Report of a Working Group of the American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778-785.
44. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
45. Zemunik T, Boban M, Lauc G, Jankovic S, Rotim K, et al. (2009) Genome-wide association study of biochemical traits in Korcula Island, Croatia. Croat Med J 50: 23-33.
46. Leduc V, Jasmin-Belanger S, Poirier J, (2010) APOE and cholesterol homeostasis in Alzheimer's disease. Trends Mol Med 16: 469-477.
47. Cirulli ET, Kasperaviciute D, Attix DK, Need AC, Ge D, et al. (2010) Common genetic variation and performance on standardized cognitive tests. Eur J Hum Genet 18: 815-820.
48. Van Manen D, Delaneau O, Kootstra NA, Boeser-Nunnink BD, Limou S, et al. (2011) Genome-Wide Association Scan in HIV-1-Infected Individuals Identifying Variants Influencing Disease Course. PLoS ONE 6: e22208.
49. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, et al. (1997) Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43: 1657-1659.
50. Van Rij RP, De Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, et al. (1998) Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 178: 1806-1811.
51. De Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, et al. (1997) Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 127: 882-890.
52. Bol SM, Van Remmerden Y, Sietzema JG, Kootstra NA, Schuitemaker H, et al. (2009) Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 390: 205-211.
53. Van Manen D, Gras L, Boeser-Nunnink BD, van Sighem AI, Maurer I, et al. (2011) Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control. AIDS 25: 2217-2226.
54. Ashton KA, Meldrum CJ, McPhillips ML, Suchy J, Kurzawski G, et al. (2006) The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria. Hered Cancer Clin Pract 4: 94-102.
55. Chen Y, Rao F, Rodriguez-Flores JL, Mahapatra NR, Mahata M, et al. (2008) Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int 74: 115-125.
56. Comings DE, MacMurray JP, (2000) Molecular heterosis: a review. Mol Genet Metab 71: 19-31.
57. Birchler JA, Auger DL, Riddle NC, (2003) In search of the molecular basis of heterosis. Plant Cell 15: 2236-2239.
58. Thomas DC, Witte JS, (2002) Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11: 505-512.
59. Banisadr G, Gosselin RD, Mechighel P, Kitabgi P, Rostene W, et al. (2005) Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 489: 275-292.
60. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, et al. (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4: 1182-1184.
61. Pemberton LA, Stone E, Price P, Van Bockxmeer F, Brew BJ, (2008) The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med 9: 677-680.
62. Diaz-Arrastia R, Gong Y, Kelly CJ, Gelman BB, (2004) Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease. J Neurovirol 10 (Suppl 1): 67-73.
63. Dunlop O, Goplen AK, Liestol K, Myrvang B, Rootwelt H, et al. (1997) HIV dementia and apolipoprotein E. Acta Neurol Scand 95: 315-318.
64. Sato-Matsumura KC, Berger J, Hainfellner JA, Mazal P, Budka H, (1998) Development of HIV encephalitis in AIDS and TNF-alpha regulatory elements. J Neuroimmunol 91: 89-92.